Form 8-K - Current report:
SEC Accession No. 0001628280-25-032358
Filing Date
2025-06-20
Accepted
2025-06-20 16:04:08
Documents
12
Period of Report
2025-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mdgl-20250620.htm   iXBRL 8-K 40856
  Complete submission text file 0001628280-25-032358.txt   163942

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdgl-20250620.xsd EX-101.SCH 1803
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mdgl-20250620_lab.xml EX-101.LAB 23471
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdgl-20250620_pre.xml EX-101.PRE 13598
14 EXTRACTED XBRL INSTANCE DOCUMENT mdgl-20250620_htm.xml XML 2953
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 251061277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)